Generality Assessment of a Model Considering Heterogeneous Cancer Cells for Predicting Tumor Control Probability for...

Area of Science:

• Radiation oncology
• Cancer stem cell biology
• Mathematical modeling in medicine

Background:

• Predicting tumor control probability (TCP) is crucial for effective radiation therapy.
• Cancer stem-like cells (CSCs) play a significant role in tumor radioresistance and recurrence.
• Existing models may not fully capture the impact of CSCs on treatment outcomes.

Purpose of the Study:

• To evaluate the generality and predictive accuracy of the integrated microdosimetric-kinetic model.
• To assess the model's performance in predicting tumor control probability for non-small cell lung cancer (NSCLC).
• To determine the model's applicability using in vitro clonogenic survival data and CSC considerations.

Main Methods:

• Utilized the integrated microdosimetric-kinetic model.
• Incorporated in vitro clonogenic survival data, accounting for cancer stem-like cells.
• Compared model predictions against public data from stereotactic body radiation therapy (SBRT) for NSCLC.

Main Results:

• The integrated microdosimetric-kinetic model demonstrated generality in predicting tumor control probability.
• Model performance was validated using stereotactic body radiation therapy data for non-small cell lung cancer.
• The model effectively integrates microdosimetric and kinetic parameters with CSC considerations.

Conclusions:

• The integrated microdosimetric-kinetic model provides a robust framework for predicting tumor control probability.
• The model's consideration of cancer stem-like cells enhances its predictive power for radiation therapy outcomes.
• This approach holds potential for optimizing SBRT in non-small cell lung cancer treatment.